Class III beta-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer-论文-万方医学网

Class III beta-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer

导出原文传递

翻译打印收藏纠错

作者： Kato, Akihisa ^[1] ; Naitoh, Itaru ^[2] ; Naiki-Ito, Aya ^[3] ; Hayashi, Kazuki ^[4] ; Okumura, Fumihiro ^[5] ; Fujita, Yasuaki ^[6] ; Sano, Hitoshi ^[7] ; Nishi, Yuji ; Miyabe, Katsuyuki ; Inoue, Tadahisa ; Hirano, Atsuyuki ; Takada, Hiroki ; Yoshida, Michihiro ; Hori, Yasuki ; Natsume, Makoto ; Kato, Hiroyuki ; Takahashi, Satoru ; Kataoka, Hiromi

作者单位： Dept Gastroenterol,Kasugai Municipal Hosp ^[1] Grad Sch Med Sci,Nagoya City Univ ^[2] Dept Gastroenterol,Gifu Prefectural Tajimi Hosp ^[3] Dept Gastroenterol,Toyokawa City Hosp ^[4] Dept Gastroenterol,Nagoya Daini Red Cross Hosp ^[5] Sch Med,Aichi Med Univ ^[6] Dept Gastroenterol,Nagoya City West Med Ctr ^[7]

关键词 class III beta-tubulin (TUBB3)unresectable pancreatic ductal adenocarcinoma (UR-PDAC)nab-paclitaxel and gemcitabine (GnP)endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)FOLFIRINOX CELL LUNG-CANCER NUCLEOSIDE TRANSPORTER 1 HUMAN PROSTATE CARCINOMA GROWTH-FACTOR RECEPTOR DUCTAL ADENOCARCINOMA ADJUVANT GEMCITABINE AMERICAN SOCIETY ANTITUMOR AGENT PHASE-III TAXOL

发布时间 2022-09-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除